Genome-wide CRISPR-Cas9 dropout screen in small cell lung cancer (SCLC) cells identified PAX9 as an essential factor that is overexpressed and is transcriptionally driven by the BAP1/ASXL3/BRD4 epigenetic axis. This evidence concerns the gene BRD4 and small cell lung carcinoma.